Mast cell cytokine and chemokine responses to bacterial and viral infection.
Mast cells have been most widely studied in the context of allergic disease but also play a critical role in host defence against bacterial infection, most elegantly demonstrated in studies using mast cell deficient w/wv mice. There is less data available concerning the role of mast cells in defence against viral pathogens, however, mast cells have been demonstrated to be a potential reservoir of infection for several pathogens, such as HIV-1 and dengue, and capable of producing mediators following challenge with a number of viral products. Traditional mast cell mediators such as histamine, protease enzymes and leukotrienes are important for effective host responses. The cytokines and chemokines produced by mast cells in response to pathogens are known to profoundly alter the nature of the innate immune response and its effectiveness in eliminating infection. Cytokine and chemokine production by mast cells is closely regulated and may occur independently of classical mast cell degranulation. Depending upon the nature of the stimulus or type of infection, a unique profile of cytokines is induced. In this review, we will examine the role and regulation of mast cell cytokines and chemokines in the context of a number of bacterial and viral infections, emphasizing the multiple receptor mechanisms used to activate mast cells. This area of research is still in its early stages and much work remains to be done. However, understanding the unique properties of resident tissue mast cells and how their cytokine responses are regulated by pathogens or pathogen products, will provide important opportunities for the therapeutic manipulation of local immune responses.
Marshall
Jean S
JS
Depts of Microbiology & Immunology and Pathology, Dalhousie University, Halifax, Nova Scotia, B3H 4H7, Canada. Jean.Marshall@Dal.ca
King
Christine A
CA
McCurdy
Jeffrey D
JD
D000818:Animals; D001424:Bacterial Infections / Q000276:immunology* / Q000378:metabolism; D018925:Chemokines / Q000096:biosynthesis* / Q000276:immunology; D029721:Drosophila Proteins; D006801:Humans; D008407:Mast Cells / Q000276:immunology / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000276:immunology; D011956:Receptors, Cell Surface / Q000276:immunology; D011951:Receptors, Complement / Q000276:immunology; D017455:Receptors, IgE / Q000276:immunology; D018089:Superantigens / Q000276:immunology; D051193:Toll-Like Receptors; D014777:Virus Diseases / Q000276:immunology* / Q000378:metabolism / Q000821:virology
D018925:Chemokines; D029721:Drosophila Proteins; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface; D011951:Receptors, Complement; D017455:Receptors, IgE; D018089:Superantigens; D051193:Toll-Like Receptors